The S&P/ASX 200 index is on course to start the week with a disappointing decline. In afternoon trade the benchmark index is down 1.15% to 6,935.9 points.
Four shares that have not let that hold them back today are listed below. Here's why they are charging higher:
The Citadel Group Ltd (ASX: CGL) share price is up 2.5% to $4.91. Investors have been buying the managed technology solutions provider's shares after it provided an update on recent contract wins. Management believes that these contract wins reflect the continued trust that Citadel's clients place in the company and the strong products and services proposition it provides in its key verticals.
The Evolution Mining Ltd (ASX: EVN) share price is up 3% to $3.82. Investors have been buying Evolution and the rest of the gold miners on Monday due to increasing demand for safe haven assets. This solid demand for the gold miners has led to the S&P/ASX All Ords Gold index climbing 1.4% this afternoon. The good news for Evolution is that this has offset an announcement which reveals that La Mancha Group has just trimmed its holding in Evolution by over 20 million shares.
The PolyNovo Ltd (ASX: PNV) share price has continued its positive run and is up a further 2% to $2.86. This latest gain means that the PolyNovo share price is now up a massive 54% since the start of the year. Investors have been buying the medical device company's shares thanks to positive developments in both the European and UK markets.
The Pro Medicus Limited (ASX: PME) share price has climbed almost 5% to $25.15. The Pro Medicus share price is racing higher on Monday despite there being no news out of the healthcare imaging software and services provider. It has also been a strong performer in 2020. This latest gain means that Pro Medicus' shares are now up 13% year to date.
